Delivery Order SPE2DB22D9310-SPE2DB25FP0MC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $38,811.00 by the Defense Logistics Agency on September 8, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. The award was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, leveraging DMS Pharmaceutical Group's established position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 Unit Vials valued at $12,937.00 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is issued under the company's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, for BOTOX 200 unit vials under a firm fixed-price contract with a ceiling value of $2,587.40. The award was issued by the Defense Logistics Agency (DLA), a defense organization responsible for supplying the Department of Defense with critical materials and services. The contract type reflects a delivery order issued against a larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,762.20 by the Defense Logistics Agency for the supply of Botox 200 unit vials. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a direct pharmaceutical supply requirement for Department of Defense healthcare facilities. The award was executed without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,775.42 by the Defense Logistics Agency on August 28, 2025, for the supply of Botox 100 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 19, 2025, and was executed with no set-aside designation. Performance will occur at the contractor's facility in Park Ridge, Illinois. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, valued at $6,468.50 with completion targeted for September 9, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award carries no set-aside...
- SPE2DB22D9310Indefinite Delivery Contract
- SPE2DB22D9310-SPE2DB25FP0MCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. This firm fixed-price delivery order, set to be completed by September 16, 2025, represents a specific pharmaceutical supply need for Department of Defense healthcare facilities. The award was issued without set-aside designation, demonstrating the company's competitive position in federal pharmaceutical procurement markets. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive portfolio of pharmaceutical products supporting military health facilities worldwide. The IDC enables efficient procurement of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables across multiple product categories. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established itself through consistent contract performance delivering specialized pharmaceutical products ranging from contraceptive devices to oncology treatments and injectable medications to Department of Defense medical installations.